Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.52 USD | -2.38% |
|
-10.26% | +161.73% |
03:47pm | Novavax: ACIP in favor of Covid 24/25 vaccine | CF |
Jun. 27 | US CDC advisers recommend updated COVID vaccines for those six months and older | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+163.96% | 1.8B | |
+38.65% | 39.1B | |
-8.35% | 38.76B | |
+27.51% | 31.24B | |
+12.42% | 25.9B | |
-13.50% | 25.8B | |
+45.25% | 14.06B | |
+37.84% | 13.12B | |
-7.05% | 11.32B | |
-12.40% | 10.68B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Novavax Seeks EU Authorization for Updated Covid-19 Vaccine